Merck Defends Inaction on Vioxx VIGOR Data, Cites Naproxen Heart Benefit
This article was originally published in The Tan Sheet
Executive Summary
Merck continues to support the cardioprotective effect of the non-steroidal anti-inflammatory drug naproxen
You may also be interested in...
Merck Legal Defense May Raise Cardioprotective Profile Of Naproxen
Liability related to Merck's Vioxx withdrawal may define the future safety profile of naproxen
Merck Legal Defense May Raise Cardioprotective Profile Of Naproxen
Liability related to Merck's Vioxx withdrawal may define the future safety profile of naproxen
Merck Legal Defense May Raise Cardioprotective Profile Of Naproxen
Liability related to Merck's Vioxx withdrawal may define the future safety profile of naproxen